跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 150 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 150 MG/ML
Approved
THERAPEUTIC
SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 150 MG/ML
AstraZeneca Nijmegen B.V. (NETHERLANDS)
🇸🇬 Health Sciences Authority
Approval Date
Sep 2, 2026
Approval ID
8778b5eb9bcee0e9
Company
AstraZeneca Nijmegen B.V. (NETHERLANDS)
Type
Therapeutic
Approval Details
Approval Id
8778b5eb9bcee0e9
Drug Name
SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 150 MG/ML
Product Name
SAPHNELO CONCENTRATE FOR SOLUTION FOR INFUSION 150 MG/ML
Approval Number
SIN17630P
Approval Date
2026-09-02
Registrant
ASTRAZENECA SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 2, 2026
Approval ID
8778b5eb9bcee0e9
Type
Therapeutic
Back to HSA Approvals
